资讯

Maven Clinic introduces male fertility support tools, Scripta Insights announces a tool to locate cost-effective meds, and XRHealth launches a new platform.
Initiatives being introduced in Taiwan, Hong Kong, and Singapore use AI and mobile technologies.
The company says the model excels in healthcare applications, outperforming previous models on real-world clinical tasks and is already being adopted by healthcare companies.
UK-based Ultromics, a company using AI for heart ultrasound diagnostics, has secured $55 million in Series C funding in a round co-led by L&G, Allegis Capital and Lightrock. Existing investors GV, ...
Google has unveiled SensorLM, a set of foundation models that analyzes multimodal wearable sensor signals from devices like smartwatches and fitness trackers to generate insights into one's health and ...
Ambience Healthcare, an ambient AI documentation company, has secured a whopping $243 million in Series C funding in a round co-led by Oak HC/FT and Andreessen Horowitz (a16z). Existing investors ...
Patients can get more access to their healthcare information when AI is used to translate patient notes in their chart into a patient-friendly language and format, says Dr. Jonah Zaretsky, medical ...
Restore Medical, a medtech company focusing on heart failure therapies, announced the closing of a $23 million Series B funding round. Pitango HealthTech co-led the round with the European Innovation ...
Healthcare technology company Aktiia has received FDA 510(k) clearance for its over-the-counter cuffless blood pressure monitor, G0 Blood Pressure Monitoring System, also known as the Hilo Band.
Editor's note: This article has been updated to include Teladoc's first quarter 2025 earning results. New York-based virtual care company Teladoc Health announced it acquired mental health platform ...
Seoul National University Hospital has developed what could be the first medical large language model in South Korea. The project to develop the medical LLM began last year in March. The SNUH research ...
Ben Wolf, partner in Alston & Bird's Health Care Group, told MobiHealthNews how FDA staffing cuts could slow device approvals and what companies can do to stay ahead.